FDA.reportPublic FDA data

esketamine 140 MG/mL Nasal Spray

RxCUI
2119381
RxNorm name
esketamine 140 MG/mL Nasal Spray
Display name
esketamine 140 MG/mL Nasal Spray
Full name
esketamine 140 MG/mL Nasal Spray
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SpravatoESKETAMINE HYDROCHLORIDEJanssen Pharmaceuticals, Inc.d81a6a79-a74a-44b7-822c-0dfa3036eaed2026-03-31Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2119381

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d81a6a79-a74a-44b7-822c-0dfa3036eaedesketamine 140 MG/mL Nasal Spray [PSN] · esketamine 140 MG/ML Nasal Spray [SCD]218These highlights do not include all the information needed to use SPRAVATO safely and effectively. See full prescribing information for SPRAVATO. SPRAVATO ® (esketamine) nasal spray, CIII Initial U.S. Approval: 1970 (ketamine)20260313